Catalyst Pharm Inc (CPRX) Stock Price, Quote & News

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 420 3200

Website: catalystpharma.com

Address:

355 Alhambra Circle, Suite 801, Coral Gables, United States

JackDarwin Mar. 21 at 8:38 AM

$CPRX Bullish Tweezer Candlestick Pattern Formed at Downtrend with Jump in Volume

0 · Reply

StillWaiting101 Mar. 20 at 7:39 PM

$CPRX relative strength here, just don't look outside, its getting rough everywhere else

0 · Reply

111ggg Mar. 20 at 1:35 PM

$CPRX what sucker paid up to buy premarket. Never buy premarket

0 · Reply

BlackSwan13 Mar. 19 at 3:00 PM

$CPRX tis stock has already managed 1 world war. can it manage another?

0 · Reply

Calinda Mar. 18 at 6:48 PM

$CPRX reposting as a stand-alone, not just a reply, to increase visibility: Update “Trial will go forward on May 18 and 19, and if necessary on the morning of May 20. And trial will go forward on May 26 and if necessary on the morning of May 27. So ordered...” These were the dates offered in the 3/6 letter from CPRX’s legal firm indicating the dates were collectively reached with defendants to establish availability of experts who could/should then testify together. IMO Hetero et al has run out of attempted trial interference / manipulation to muddy the waters with failing expertise.

0 · Reply

Sowa5000 Mar. 18 at 12:44 PM

$CPRX Anybody got anything on the court case wondering if you think they settle before Friday. I know they have already settled with 2 of the 3. Need a quick settlement or could get ugly.

2 · Reply

zyx123 Mar. 16 at 8:21 PM

$CPRX what's with that candle at close? Maybe good news regarding trial?

1 · Reply

Starrider111 Mar. 13 at 2:32 PM

I bought $CPRX & $WY today

0 · Reply

StillWaiting101 Mar. 13 at 2:05 PM

$CPRX seems like a perfect time for me to start buying

1 · Reply

111ggg Mar. 13 at 1:51 PM

$CPRX within 30 days we should know which direction she goes.

0 · Reply

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 6, 2026, 8:03 AM EST - 15 days ago

Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference

Feb 26, 2026, 3:27 PM EST - 23 days ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 4:07 PM EST - 24 days ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Feb 24, 2026, 8:03 AM EST - 25 days ago

Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference

Feb 19, 2026, 11:39 AM EST - 4 weeks ago

Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs

Feb 11, 2026, 8:03 AM EST - 5 weeks ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

Jan 12, 2026, 9:25 PM EST - 2 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 8, 2026, 8:03 AM EST - 2 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies

Dec 15, 2025, 8:03 AM EST - 3 months ago

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 8, 2025, 4:07 PM EST - 3 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript

Dec 2, 2025, 4:43 PM EST - 3 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 24, 2025, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Nov 19, 2025, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™

Nov 18, 2025, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

Nov 6, 2025, 8:36 PM EST - 4 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:06 PM EST - 4 months ago

Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 4, 2025, 4:03 PM EST - 4 months ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work

Nov 3, 2025, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

Oct 22, 2025, 8:03 AM EDT - 5 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 9, 2025, 8:03 AM EDT - 5 months ago

Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

Oct 1, 2025, 8:03 AM EDT - 6 months ago

Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program

Aug 28, 2025, 8:03 AM EDT - 7 months ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 26, 2025, 7:12 PM EDT - 7 months ago

UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Aug 25, 2025, 8:03 AM EDT - 7 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Aug 7, 2025, 2:21 PM EDT - 8 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:13 PM EDT - 8 months ago

Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update

Aug 6, 2025, 8:03 AM EDT - 8 months ago

Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)

Aug 4, 2025, 8:03 AM EDT - 8 months ago

Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors

Jul 22, 2025, 8:03 AM EDT - 8 months ago

Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025

Jun 11, 2025, 7:08 AM EDT - 10 months ago

Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:00 AM EDT - 10 months ago

20 stocks you should avoid — no matter how well the market does

CORT CRK CRNC DDD LUMN LYV MGPI

Jun 2, 2025, 8:03 AM EDT - 10 months ago

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

May 31, 2025, 5:18 AM EDT - 10 months ago

Catalyst: Solid Business Model Propels Growth For This Buy And Build Pharma

May 8, 2025, 12:02 PM EDT - 11 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:14 PM EDT - 11 months ago

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Apr 30, 2025, 8:03 AM EDT - 11 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Apr 22, 2025, 8:03 AM EDT - 11 months ago

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 8, 2025, 8:06 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

Mar 26, 2025, 8:12 AM EDT - 1 year ago

Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 11, 2025, 4:05 AM EDT - 1 year ago

Catalyst Pharmaceuticals: Undervalued Future With Multiple Upside Catalysts

Mar 4, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Mar 3, 2025, 2:39 PM EST - 1 year ago

Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges

Feb 27, 2025, 12:29 PM EST - 1 year ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:13 PM EST - 1 year ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 12, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Feb 7, 2025, 3:56 PM EST - 1 year ago

Catalyst Remains a Big Money Favorite

Jan 23, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Jan 21, 2025, 8:19 AM EST - 1 year ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

Jan 13, 2025, 8:30 AM EST - 1 year ago

Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE

JackDarwin Mar. 21 at 8:38 AM

$CPRX Bullish Tweezer Candlestick Pattern Formed at Downtrend with Jump in Volume

0 · Reply

StillWaiting101 Mar. 20 at 7:39 PM

$CPRX relative strength here, just don't look outside, its getting rough everywhere else

0 · Reply

111ggg Mar. 20 at 1:35 PM

$CPRX what sucker paid up to buy premarket. Never buy premarket

0 · Reply

BlackSwan13 Mar. 19 at 3:00 PM

$CPRX tis stock has already managed 1 world war. can it manage another?

0 · Reply

Calinda Mar. 18 at 6:48 PM

0 · Reply

Sowa5000 Mar. 18 at 12:44 PM

$CPRX Anybody got anything on the court case wondering if you think they settle before Friday. I know they have already settled with 2 of the 3. Need a quick settlement or could get ugly.

2 · Reply

zyx123 Mar. 16 at 8:21 PM

$CPRX what's with that candle at close? Maybe good news regarding trial?

1 · Reply

Starrider111 Mar. 13 at 2:32 PM

I bought $CPRX & $WY today

0 · Reply

StillWaiting101 Mar. 13 at 2:05 PM

$CPRX seems like a perfect time for me to start buying

1 · Reply

111ggg Mar. 13 at 1:51 PM

$CPRX within 30 days we should know which direction she goes.

0 · Reply

BlackSwan13 Mar. 12 at 10:19 PM

$CPRX Judge Michael E. Farbiarz of the U.S. District Court for the District of New Jersey, do the right thing!!

0 · Reply

Cooco Mar. 12 at 7:04 PM

$CPRX sad that im stuck

1 · Reply

BoltTrade Mar. 11 at 6:07 PM

$SXTP has gone up 55% and still only 2,391 people are watching this stock. Clinical results came in, and all 3 patients were CURED! Let’s talk about 🚀🚀🚀 $VRTX $BNTX $MRNA $CPRX

0 · Reply

StillWaiting101 Mar. 11 at 4:02 PM

$CPRX give me under $24 again, I don't mind another chance to swing $23.xx to $25

2 · Reply

Doozio Mar. 11 at 4:56 AM

$CPRX 3/2 MNDY 🐑 appears obvious ENTA 🐒🍌🧠⏰♾️.

0 · Reply

BioTechHealthX Mar. 8 at 4:28 PM

$CPRX Catalyst Pharmaceuticals (NASDAQ: CPRX) just posted record revenue and strong growth driven by blockbuster therapies like FIRDAPSE and AGAMREE. With biotech investors hunting for undervalued opportunities, CPRX is gaining attention as a cheap biotech stock showing strong fundamentals and expanding market demand. https://biotechhealthx.com/biotech-news/is-it-a-wise-move-to-acquire-catalyst-pharmaceuticals-cprx-shares/

0 · Reply

BioTechHealthX Mar. 6 at 5:40 PM

$AUPH $BMRN $CPRX $HALO $HRMY Biotech stocks may be starting slow this year, but analysts believe the sector could be setting up for a powerful comeback. With massive pharmaceutical patent expirations approaching and over $1 trillion in industry capital ready for deals, these cheap biotech stocks could offer significant upside for investors searching for undervalued healthcare opportunities. https://biotechhealthx.com/biotech-news/10-cheap-biotech-stocks-to-buy-now/

0 · Reply

111ggg Mar. 5 at 4:46 PM

$CPRX that 25 is a rock solid top until lawsuit is settled. Then it might see 30 or break 20 depending on decision.

3 · Reply

erevnon Mar. 3 at 7:16 PM

Citigroup maintains Catalyst Pharmaceuticals $CPRX at Buy and raises the price target from $33 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

ClarVal Mar. 3 at 4:14 AM

$CPRX https://clarval.com/?ticker=CPRX

0 · Reply

WB_Bull Mar. 2 at 9:08 PM

$CPRX what happened? 1,4 mio shares in 1 hour ! are there news around the corner? good luck

1 · Reply

sunset_PARK Mar. 2 at 8:52 PM

$CPRX $KNSA $TARS they all moved last 30mins withvolume, similar market cap in bio, any news, any others? Seems not in the same index?

1 · Reply

Market Cap	2.78B
Revenue (ttm)	588.99M
Net Income (ttm)	214.33M
EPS (ttm)	N/A
PE Ratio	8.83
Forward PE	8.28
Profit Margin	36.39%
Debt to Equity Ratio	0.00

Volume	3,188,800
Avg Vol	1,269,230
Day's Range	N/A - N/A
Shares Out	122.12M
Stochastic %K	19%
Beta	0.75
Analysts	Strong Sell
Price Target	$34.86